A longer breast carcinoma screening interval for women age older than 65 years ?
The observed increase in sojourn time for preclinical breast carcinoma raises the question of whether women age >= 65 years can be screened less frequently than younger women.
A cost-utility analysis using a computer model that simulates the demography, epidemiology, and natural history of breast carcinoma to estimate expected life-years gained, extra incidence, extra life-years with disease, and costs incurred by different breast carcinoma screening programs in the general population was conducted.
The estimated ratio of favorable/unfavorable effects was lower for longer screening intervals compared with shorter screening intervals.
The cost-effectiveness ratio was much less favorable in shorter screening intervals.
The results of the current analysis showed that although a longer sojourn time for preclinical breast carcinoma should not necessarily be accompanied by a longer screening interval, a shorter screening interval was not very efficient.
Mots-clés Pascal : Carcinome, Glande mammaire, Dépistage, Intervalle temps, Analyse avantage coût, Economie santé, Pays Bas, Europe, Femelle, Personne âgée, Homme, Tumeur maligne, Glande mammaire pathologie
Mots-clés Pascal anglais : Carcinoma, Mammary gland, Medical screening, Time interval, Cost benefit analysis, Health economy, Netherlands, Europe, Female, Elderly, Human, Malignant tumor, Mammary gland diseases
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0503962
Code Inist : 002B20E02. Création : 22/03/2000.